Pharmafile Logo

TechnologyAdvice

Eli Lilly HQ

Lilly planning early re-file for JAK inhibitor baricitinib

The arthritis treatment could reach US market a year earlier than expected

- PMLiVE

Three ‘finalist’ nominations for Porterhouse Medical in the 2017 Women in Business Awards

The 2017 Women in Business Awards shortlist (http://womeninbusiness.biz/wib-awards-2017/) includes an impressive three ‘finalist’ nominations for Porterhouse Medical across three award categories. Senior Medical Writers Lisa Gallacher and Gillian Hancey have...

Porterhouse Medical Group

- PMLiVE

Sanofi looks to mobile data to power behavioural analysis

Teams up with Evidation Health for a new digital health partnership

- PMLiVE

McCann Echo strengthens leadership team

Promotes Jesse Johanson as its president

Life at the end of the Brexit tunnel

A new proposal to maintain the UK as a benchmark of excellence in Life Sciences

Life Healthcare Communications

- PMLiVE

Merck & Co’s anacetrapib data fails to generate much excitement

Treatment proves unable to reduce a composite outcome of major atherosclerotic events

Biogen Idec building

Biogen says trial extension data keep Alzheimer’s drug on track

Releases updated results from the PRIME trial of anti-amyloid drug aducanumab

- PMLiVE

EUSA receives European green light for kidney cancer treatment Fotivda

European Commission approves the drug to treat RCC

- PMLiVE

Boehringer Ingelheim launches new digital innovation team

BI X will aim to accelerate research and development

- PMLiVE

mXm launches mXm Health Consulting

Strategic consulting arm to operate alongside mXm Medical Communications

- PMLiVE

Almirall appoints Peter Guenter as its CEO

He joins from Sanofi where he was executive vice president

- PMLiVE

Germany will be first EU launch market for new Soliris indication

Alexion 'currently evaluating' additional European launches for its orphan drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links